Aureon Biosciences, Inc. — Form D
Aureon Biosciences, Inc. of YONKERS, NY, a company, filed a Form D exempt-offering notice with the SEC on 2010-03-02. The offering totals $18.0M, of which $7.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-03-02
- Form: D
- Accession: 0001331514-10-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $18.0M
- Amount sold: $7.0M
- Remaining: $11.0M
- Investors: 17
- Date of first sale: 2010-02-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-78598
Issuer
- Name: Aureon Biosciences, Inc.
- CIK: 0001331514
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 28 WELLS AVE, YONKERS, NY, 10701
- Phone: 914-377-4000
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Robert Van Nostrand | Executive Officer | Yonkers, NY |
| Kevin Johnson | Director | San Diego, CA |
| William Burkoth | Director | Ann Arbor, MI |
| Jose Costa, M.D. | Director | New Haven, CT |
| Paul Veronese | Director | Yonkers, NY |
| Robert Shovlin | Director | Yonkers, NY |
| Robert Shovlin | Executive Officer | Yonkers, NY |
| Peter Barrett, Ph.D. | Director | Cambridge, MA |
| Carlos Cordon-Cardo, M.D., Ph.D. | Director | New York, NY |
| Philippe Chambon, M.D., Ph.D. | Director | New York, NY |
| Jose Velasco, M.D. | Director | Yonkers, NY |
| Vijay Aggarwal, Ph.D. | Director | Yonkers, NY |
Other filings by this issuer (6)
More